Assignee
VASCULAR BIOGENICS LTD
IL·35 granted patents·26 pending applications·464 citations·filing 2002–2022
Top patents by PatentIndex Score
61 records- 0196US7973023B2Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disordersVASCULAR BIOGENICS LTD·Filed 2009·Granted Jul 5, 2011·31 cites·51 claims
- 0296US7504388B2Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosisVASCULAR BIOGENICS LTD·Filed 2005·Granted Mar 17, 2009·31 cites·7 claims
- 0396US6838452B2Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosisVASCULAR BIOGENICS LTD·Filed 2003·Granted Jan 4, 2005·62 cites·11 claims
- 0495US7893291B2Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosisVASCULAR BIOGENICS LTD·Filed 2009·Granted Feb 22, 2011·24 cites·3 claims
- 0595US7807847B2Process for the preparation of oxidized phospholipidsVASCULAR BIOGENICS LTD·Filed 2007·Granted Oct 5, 2010·17 cites·7 claims
- 0695US7625882B2Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disordersVASCULAR BIOGENICS LTD·Filed 2006·Granted Dec 1, 2009·31 cites·56 claims
- 0793US7989427B2Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapyVASCULAR BIOGENICS LTD·Filed 2008·Granted Aug 2, 2011·21 cites·6 claims
- 0893US7186704B2Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosisVASCULAR BIOGENICS LTD·Filed 2003·Granted Mar 6, 2007·31 cites·16 claims
- 0992US9566288B2High-purity phospholipidsVASCULAR BIOGENICS LTD·Filed 2015·Granted Feb 14, 2017·5 cites·35 claims
- 1092US8569529B2High-purity phospholipidsVASCULAR BIOGENICS LTD·Filed 2012·Granted Oct 29, 2013·8 cites·20 claims
- 1192US8039261B2Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesisVASCULAR BIOGENICS LTD·Filed 2006·Granted Oct 18, 2011·27 cites·39 claims
- 1292US7902176B2Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disordersVASCULAR BIOGENICS LTD·Filed 2004·Granted Mar 8, 2011·31 cites·107 claims
- 1391US11697682B2Motile sperm domain containing protein 2 antibodies and methods of use thereofVASCULAR BIOGENICS LTD·Filed 2021·Granted Jul 11, 2023·2 cites·29 claims
- 1491US8802875B2Process for the preparation of oxidized phospholipidsVASCULAR BIOGENICS LTD·Filed 2012·Granted Aug 12, 2014·5 cites·14 claims
- 1591US7067649B2Promoters exhibiting endothelial cell specificity and methods of using sameVASCULAR BIOGENICS LTD·Filed 2002·Granted Jun 27, 2006·40 cites·19 claims
- 1690US9006217B2High-purity phospholipidsVASCULAR BIOGENICS LTD·Filed 2013·Granted Apr 14, 2015·5 cites·22 claims
- 1790US7585666B2Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapyVASCULAR BIOGENICS LTD·Filed 2002·Granted Sep 8, 2009·29 cites·5 claims
- 1889US10383954B2Methods of inducing responsiveness to anti-angiogenic agentVASCULAR BIOGENICS LTD·Filed 2017·Granted Aug 20, 2019·4 cites·18 claims
- 1989US8759557B2Process for the preparation of oxidized phospholipidsVASCULAR BIOGENICS LTD·Filed 2013·Granted Jun 24, 2014·4 cites·13 claims
- 2088US7579327B2Promoters exhibiting endothelial cell specificity and methods of using sameVASCULAR BIOGENICS LTD·Filed 2004·Granted Aug 25, 2009·23 cites·10 claims
- 2187US9968622B2High-purity phospholipidsVASCULAR BIOGENICS LTD·Filed 2017·Granted May 15, 2018·2 cites·18 claims
- 2287US9682154B2Methods of inducing responsiveness to anti-angiogenic agentVASCULAR BIOGENICS LTD·Filed 2014·Granted Jun 20, 2017·6 cites·20 claims
- 2384US8859747B2Promoters exhibiting endothelial cell specificity and methods of using sameVASCULAR BIOGENICS LTD·Filed 2013·Granted Oct 14, 2014·5 cites·31 claims
- 2483US8916378B2Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulations of angiogenesis and anticancer therapyVASCULAR BIOGENICS LTD·Filed 2013·Granted Dec 23, 2014·4 cites·20 claims
- 2582US11191848B2Methods of inducing responsiveness to anti-angiogenic agentVASCULAR BIOGENICS LTD·Filed 2019·Granted Dec 7, 2021·1 cites·16 claims
- 2681US11311583B2Treatment methods using adenovirusVASCULAR BIOGENICS LTD·Filed 2018·Granted Apr 26, 2022·1 cites·11 claims
- 2781US9771385B2Oxidized lipidsVASCULAR BIOGENICS LTD·Filed 2015·Granted Sep 26, 2017·2 cites·37 claims
- 2878US9200056B2FAS-chimera adenovirus vectorVASCULAR BIOGENICS LTD·Filed 2014·Granted Dec 1, 2015·3 cites·23 claims
- 2977US10022388B2Oxidized lipids and treatment or prevention of fibrosisVASCULAR BIOGENICS LTD·Filed 2017·Granted Jul 17, 2018·2 cites·19 claims
- 3077US9254297B2Formulations and dosage forms of oxidized phospholipidsVASCULAR BIOGENICS LTD·Filed 2013·Granted Feb 9, 2016·5 cites·37 claims
- 3172US7279459B2Methods employing and compositions containing plaque associated molecules for prevention and treatment of atherosclerosisVASCULAR BIOGENICS LTD·Filed 2002·Granted Oct 9, 2007·2 cites·8 claims
- 3271US2022331383A1Treatment methods using adenovirusVASCULAR BIOGENICS LTD·Filed 2022·Application pending·0 cites
- 3368US2010081193A1Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesisVASCULAR BIOGENICS LTD·Filed 2009·Application pending·0 cites
- 3460US2013280217A1Methods for Use of a Specific Anti-Angiogenic Adenoviral AgentVASCULAR BIOGENICS LTD·Filed 2013·Application pending·0 cites
- 3560US2013280216A1Methods for Use of a Specific Anti-Angiogenic Adenoviral AgentVASCULAR BIOGENICS LTD·Filed 2013·Application pending·0 cites
- 3658US2010298226A1Polypeptides and polynucleotides encoding same and use thereof in the treatment of medical conditions associated with ischemiaVASCULAR BIOGENICS LTD·Filed 2007·Application pending·0 cites
- 3757US9403887B2Endothelial cell-specific polynucleotides and use thereofVASCULAR BIOGENICS LTD·Filed 2014·Granted Aug 2, 2016·0 cites·23 claims
- 3855US2013225525A1Combined Treatment Utilizing VB-201VASCULAR BIOGENICS LTD·Filed 2013·Application pending·0 cites
- 3955US2022154212A1Methods of anti-tumor therapyVASCULAR BIOGENICS LTD·Filed 2020·Application pending·0 cites
- 4055US2011201677A1Promoters exhibiting endothelial cell specificity and methods of using sameVASCULAR BIOGENICS LTD·Filed 2011·Application pending·0 cites
- 4155US2011207985A1Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesisVASCULAR BIOGENICS LTD·Filed 2011·Application pending·0 cites
- 4254US2007286845A1Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesisVASCULAR BIOGENICS LTD·Filed 2007·Application pending·0 cites
- 4353US2013295053A1Methods of Producing Adenovirus Vectors and Viral Preparations Generated TherebyVASCULAR BIOGENICS LTD·Filed 2013·Application pending·0 cites
- 4451US10206936B2Oxidized lipids and treatment or prevention of fibrosisVASCULAR BIOGENICS LTD·Filed 2018·Granted Feb 19, 2019·0 cites·22 claims
- 4551US2016143968A1Treatment methods using adenovirusVASCULAR BIOGENICS LTD·Filed 2015·Application pending·0 cites
- 4651US2022185891A1Methods of anti-tumor therapyVASCULAR BIOGENICS LTD·Filed 2020·Application pending·0 cites
- 4751US2014155467A1Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesisVASCULAR BIOGENICS LTD·Filed 2013·Application pending·0 cites
- 4850US2019008880A1Formulations and Dosage Forms of Oxidized PhospholipidsVASCULAR BIOGENICS LTD·Filed 2018·Application pending·0 cites
- 4950US2005197283A1Compositions containing beta 2-glycoprotein I for the prevention and/or treatment of vascular diseaseVASCULAR BIOGENICS LTD·Filed 2005·Application pending·0 cites
- 5048US10369196B2Compositions and methods for treating glioblastoma GBMVASCULAR BIOGENICS LTD·Filed 2013·Granted Aug 6, 2019·0 cites·17 claims
Showing the top 50 of 61 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →